Sunshine Biopharma (SBFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 28 | 17 | 15 | 11 | 11 |
| Cost of Goods | 11 | 6 | 5 | 4 | 4 |
| Gross Profit | 18 | 11 | 10 | 7 | 6 |
| Operating Expenses | 371 | 84 | 144 | 49 | 260 |
| Operating Income | -343 | -67 | -129 | -38 | -251 |
| Interest Expense | 105 | 22 | 24 | 16 | 23 |
| Other Income | -635 | -609 | -755 | -40 | -123 |
| Pre-tax Income | -1,084 | -699 | -907 | -94 | -397 |
| Net Income Continuous | -1,084 | -699 | -907 | -94 | -397 |
| Net Income | $-1,084 | $-699 | $-907 | $-94 | $-979 |
| EPS Basic Total Ops | -5,440.00 | 0.00 | -20.00 | 0.00 | 160.00 |
| EPS Basic Continuous Ops | -5,437.16 | -4.97 | -11.86 | -5.02 | 40.00 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | 140.00 |
| EPS Diluted Total Ops | -5,440.00 | 0.00 | -20.00 | 0.00 | 160.00 |
| EPS Diluted Continuous Ops | -5,437.16 | -4.97 | -11.86 | -5.02 | 40.00 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | 140.00 |
| EBITDA(a) | $-340 | $-64 | $-125 | $-34 | $-246 |